title: [Better AVK treatment with self monitoring. Dosage can be regulated in time].
abstract: As long-term anticoagulant treatment, with warfarin for instance, is associated with a risk of both thrombotic and thrombolytic complications, blood testing for dose regulation is necessary at 3-8-week intervals, which is expensive and inconvenient for patients who must take time off work and travel to and fro. A new technique, using small portable monitors designed for home use by patients, makes self-management of anticoagulant treatment possible. In Germany, over 25,000 patients had their own monitor by the end of 1998. After appropriate instruction, the German patients are able to monitor their prothrombin time and adjust their anticoagulant treatment accordingly. In case of problems they contact their GP. In a two-year pilot study conducted at the Anticoagulation Clinic of Sahlgrenska University Hospital, Gothenburg, in 1996-98, where 51 patients on long-term anticoagulant treatment were trained in self-management, the results of over 1,000 patient-hours of treatment showed self-management to be at least as safe as management by the clinic. The level of patient satisfaction is high, in terms of safety and freedom from regular hospital attendance during working hours, and the convenience of self-monitoring on holiday or business trips. As the patients do their testing once a week, the risk of complications is also reduced.
authors.affiliation: Koagulationscentrum, Sahlgrenska Universitetssjukhuset, Göteborg.
authors.forename: L
authors.initials: L
authors.lastname: Stigendal
authors.forename: U
authors.initials: U
authors.lastname: André
authors.forename: B
authors.initials: B
authors.lastname: Christenson
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001780:Blood Coagulation Tests / Q000191:economics / Q000295:instrumentation / Q000592:standards; D005858:Germany; D006801:Humans; D010353:Patient Education as Topic; D017060:Patient Satisfaction; D010865:Pilot Projects; D011517:Prothrombin Time; D011785:Quality Assurance, Health Care; D011788:Quality of Life; D012648:Self Care; D013548:Sweden; D014812:Vitamin K / Q000097:blood*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D014812:Vitamin K; D014859:Warfarin
vernacular_title: Bättre AVK-terapi med egenkontroll. Dosen kan justeras i tid.